149 related articles for article (PubMed ID: 10561260)
21. Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study.
Skarlos DV; Aravantinos G; Kosmidis P; Athanassiadis A; Stathopoulos GP; Pavlidis N; Bafaloukos D; Karphathios S; Papakostas P; Bamia C; Fountzilas G
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-57-S15-61. PubMed ID: 9346224
[TBL] [Abstract][Full Text] [Related]
22. Combined intraperitoneal and intravenous chemotherapy for women with optimally debulked ovarian cancer: results from an intergroup phase II trial.
Rothenberg ML; Liu PY; Braly PS; Wilczynski SP; Hannigan EV; Wadler S; Stuart G; Jiang C; Markman M; Alberts DS
J Clin Oncol; 2003 Apr; 21(7):1313-9. PubMed ID: 12663720
[TBL] [Abstract][Full Text] [Related]
23. Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer.
Neijt JP; Engelholm SA; Tuxen MK; Sorensen PG; Hansen M; Sessa C; de Swart CA; Hirsch FR; Lund B; van Houwelingen HC
J Clin Oncol; 2000 Sep; 18(17):3084-92. PubMed ID: 10963636
[TBL] [Abstract][Full Text] [Related]
24. Outpatient platinum-taxane intraperitoneal chemotherapy regimen for ovarian cancer.
Seamon LG; Carlson MJ; Richardson DL; Cohn DE; Fowler JM; Copeland LJ; O'Malley DM
Int J Gynecol Cancer; 2009 Oct; 19(7):1195-8. PubMed ID: 19823054
[TBL] [Abstract][Full Text] [Related]
25. Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study.
Muggia FM; Braly PS; Brady MF; Sutton G; Niemann TH; Lentz SL; Alvarez RD; Kucera PR; Small JM
J Clin Oncol; 2000 Jan; 18(1):106-15. PubMed ID: 10623700
[TBL] [Abstract][Full Text] [Related]
26. Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic or unresectable localized non-small-cell lung cancer.
Kim YH; Kim JS; Choi YH; In KH; Park HS; Hong DS; Jeong TJ; Lee YY; Nam E; Lee SN; Lee KS; Kim HK
Int J Clin Oncol; 2002 Apr; 7(2):114-9. PubMed ID: 12018108
[TBL] [Abstract][Full Text] [Related]
27. Docetaxel and cisplatin in patients with advanced or recurrent gastric cancer: a multicenter phase I/II study.
Mitachi Y; Sakata Y; Ohtsu A; Hyodo I; Katsu K; Sairenji M; Saitoh S; Suwa T; Sato T; Miyata Y
Gastric Cancer; 2002; 5(3):160-7. PubMed ID: 12378343
[TBL] [Abstract][Full Text] [Related]
28. Role of docetaxel in the treatment of newly diagnosed advanced ovarian cancer.
Vasey PA
J Clin Oncol; 2003 May; 21(10 Suppl):136s-144s. PubMed ID: 12743129
[TBL] [Abstract][Full Text] [Related]
29. A multicenter phase II study of cisplatin and docetaxel (Taxotere) in the first-line treatment of advanced ovarian cancer: a GINECO study.
Diéras V; Guastalla JP; Ferrero JM; Curé H; Weber B; Winckel P; Lortholary A; Mayer F; Paraiso D; Magherini E; Pujade-Lauraine E
Cancer Chemother Pharmacol; 2004 Jun; 53(6):489-95. PubMed ID: 14767617
[TBL] [Abstract][Full Text] [Related]
30. Utilization of an Alternative Docetaxel-based Intraperitoneal Chemotherapy Regimen in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma: A Continued Need for Ovarian Cancer Patients.
Becker DA; Leath CA; Walters-Haygood CL; Smith BQ; Bevis KS
Am J Clin Oncol; 2019 Jan; 42(1):12-16. PubMed ID: 29782365
[TBL] [Abstract][Full Text] [Related]
31. A dose escalation study of weekly docetaxel in patients with advanced solid tumors.
Kouroussis C; Agelaki S; Mavroudis D; Souglakos J; Kakolyris S; Kalbakis K; Vardakis N; Reppa D; Hatzidaki D; Samonis G; Georgoulias V
Cancer Chemother Pharmacol; 2000; 46(6):488-92. PubMed ID: 11138462
[TBL] [Abstract][Full Text] [Related]
32. Docetaxel + 5-fluorouracil + cisplatin 3-day combination chemotherapy as a first-line treatment in patients with unresectable gastric cancer.
Oh DY; Kim TY; Kwon JH; Lee JJ; Joh Y; Kim DW; Kim TY; Heo DS; Bang YJ; Kim NK
Jpn J Clin Oncol; 2005 Jul; 35(7):380-5. PubMed ID: 15976069
[TBL] [Abstract][Full Text] [Related]
33. Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO).
Roth AD; Maibach R; Martinelli G; Fazio N; Aapro MS; Pagani O; Morant R; Borner MM; Herrmann R; Honegger H; Cavalli F; Alberto P; Castiglione M; Goldhirsch A
Ann Oncol; 2000 Mar; 11(3):301-6. PubMed ID: 10811496
[TBL] [Abstract][Full Text] [Related]
34. Combined cisplatin and carboplatin chemotherapy for treatment of advanced epithelial ovarian cancer.
Gershenson DM; Morris M; Burke TW; Levenback C; Kavanagh JJ; Fromm GL; Silva EG; Warner D; Wharton JT
Gynecol Oncol; 1995 Sep; 58(3):349-55. PubMed ID: 7672700
[TBL] [Abstract][Full Text] [Related]
35. Phase II study with fractionated schedule of docetaxel and cisplatin in patients with advanced non-small cell lung cancer.
Kwon JH; Kim JH; Lee JA; Shin HC; Kim HJ; Song HH; Jung JY; Kim HY; Choi DR; Kim HS; Park YI; Zang DY
Cancer Chemother Pharmacol; 2010 Oct; 66(5):889-97. PubMed ID: 20091311
[TBL] [Abstract][Full Text] [Related]
36. A clinical phase II study of a non-anthracycline sequential combination of cisplatin-vinorelbine followed by docetaxel as first-line treatment in metastatic breast cancer.
Shamseddine AI; Otrock ZK; Khalifeh MJ; Yassine HR; Charafeddine M; Abdel-Khalek Z; Chehal A; Bitar N; Jalloul R; Dheiny M; Dandashi A; Wehbeh M; El-Saghir NS
Oncology; 2006; 70(5):330-8. PubMed ID: 17164589
[TBL] [Abstract][Full Text] [Related]
37. Docetaxel and cisplatin in metastatic urothelial cancer: a phase II study.
Sengeløv L; Kamby C; Lund B; Engelholm SA
J Clin Oncol; 1998 Oct; 16(10):3392-7. PubMed ID: 9779718
[TBL] [Abstract][Full Text] [Related]
38. Docetaxel in combination with carboplatin for chemo-naive patients with epithelial ovarian cancer.
Aoki Y; Sato T; Tsuneki I; Watanabe M; Kase H; Fujita K; Kurata H; Tanaka K
Int J Gynecol Cancer; 2002; 12(6):704-9. PubMed ID: 12445246
[TBL] [Abstract][Full Text] [Related]
39. The integration of docetaxel into first-line chemotherapy for ovarian cancer.
Kaye SB;
Int J Gynecol Cancer; 2001; 11 Suppl 1():31-3. PubMed ID: 11489000
[TBL] [Abstract][Full Text] [Related]
40. Docetaxel, ifosfamide and cisplatin in solid tumour treatment: a phase I study.
Specenier P; Rasschaert M; Van den Brande J; Dyck J; Schrijvers D; Huizing MT; Vermorken JB
Anticancer Drugs; 2010 Mar; 21(3):306-12. PubMed ID: 20087171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
